Atara Biotherap (ATRA)

$7.52 0.00 (0.00%)

16:00 EDT ATRA Stock Quote Delayed 30 Minutes

ATRA Stock Earnings: Atara Biotherapeutics Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

ATRA stock results show that Atara Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q4 2023

Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Volume:

Previous Close -

Market Cap 760.29M

PE Ratio -11.06

EPS -0.68

Volume (Avg. Vol.)

Day's Range -

52-Week Range $0.20 - $10.

Dividend & Yield N/A (N/A)

ATRA Stock Predictions, Articles, and Atara Biotherap News

3 Doomed Biotech Stocks Destined for Disaster

By Alex Sirois, InvestorPlace Contributor Jul 17, 2023

Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures.

3 Stocks to Buy That Could Be the Next Biotech Breakthrough

By Larry Ramer, InvestorPlace Contributor Apr 16, 2023

Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 20, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jul 13, 2022

Good morning, investors! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 14, 2021

Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday!

7 Stocks That Could Double by Summer

By Tom Taulli, InvestorPlace Contributor Apr 5, 2021

These seven stocks may be risky, but they also have the potential for big returns -- as all of them are stocks that could double by summer.

7 Disruptive Biotech Stocks to Buy for 2025

By Harriet Lefton, Writer, TipRanks Apr 27, 2020

RBC Capital has peered into its crystal ball to reveal some of the market's most exciting biotech stocks. Here are seven that stand out.

5 Biotech Stocks to Sell Amid the Latest Slaughter

By Anthony Mirhaydari, InvestorPlace Market Strategist Feb 28, 2018

These five biotech stocks are being hit particularly hard right now. Here's what investors should know about each of these stocks to sell.

Atara Biotherap (ATRA)

ATRA Stock Earnings: Atara Biotherapeutics Beats EPS, Beats Revenue for Q1 2024

ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q4 2023

Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Atara Biotherap (ATRA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ATRA Stock Predictions, Articles, and Atara Biotherap News

Subscriber Sign in